Accumulating signs have found that long noncoding RNAs (lncRNAs) contribute to
hepatocellular carcinoma (HCC). Here, we probed the effect and mechanism of
lncRNA DARS-AS1 in HCC. The profiles of DARS-AS1 and Cytoskeleton associated
protein 2 (CKAP2) in 50 HCC tissues and non-
tumor tissues were examined by real-time quantitative polymerase chain reaction (RT-qPCR). DARS-AS1 and CKAP2 overexpression and/or knockdown cell models were established. The proliferation, apoptosis, invasion and epithelial-mesenchymal transition (EMT) were determined. CKAP2, and
focal adhesion kinase (FAK)-
extracellular signal-regulated kinase (ERK) was tested by Western blot (WB). The relationship between DARS-AS1 and CKAP2 was predicted by Bioinformatics, and the dual-
luciferase reporter assay was applied to verify the targeting association between miR-3200-5p and DARS-AS1 and CKAP2. DARS-AS1 was overexpressed in HCC tissues (vs. that in non-
tumor tissues) and was closely correlated with the patients'
tumor stage. DARS-AS1 facilitated HCC cell proliferation and hampered apoptosis. HCC cell migration and EMT were enhanced by DARS-AS1. DARS-AS1 up-regulated CKAP2, which aggravated HCC. Further investigation illustrated that either DARS-AS1 or CKAP2 activated FAK-ERK pathway, and miR-3200-5p was competitively restrained by DARS-AS1. miR-3200-5p exerted
tumor-suppressive effects in HCC and inactivated CKAP2 and FAK-ERK pathway. All in all, this study corroborates that DARS-AS1 facilitates HCC proliferation and
metastasis by regulating miR-3200-5p-mediated CKAP2, which provides a potential target for HCC diagnosis and treatment.Abbreviations: CCK-8: cell counting kit-8; CKAP2: Cytoskeleton associated
protein 2;
cDNA:
complementary DNA;
DAPI: 4',6-diamidino-2-phenylindole; DARS-AS1: DARS1
antisense RNA 1; DEPC:
diethyl pyrocarbonate; DMEM-F12: Dulbecco's minimal essential medium/Ham's-F12; EMT: epithelial-mesenchymal transition; ERK:
extracellular signal-regulated kinase; FAK:
focal adhesion kinase; FBS:
fetal bovine serum; GAPDH:
glyceraldehyde-3-phosphate dehydrogenase; HCC:
hepatocellular carcinoma; HE:
hematoxylin-
eosin; IHC: Immunohistochemistry; LIHC: Liver
hepatocellular carcinoma; lncRNAs: long noncoding RNAs; MIAT:
lncRNA myocardial infarction-related transcripts; MT: Mutant; NC: negative control; PBS:
phosphate-buffered saline; PMSF:
Phenylmethylsulfonyl fluoride;
PVDF:
polyvinylidene difluoride; RT: room temperature; RT-qPCR: real-time quantitative polymerase chain reaction; SDS-PAGE:
sodium dodecyl sulfate-
polyacrylamide gel electrophoresis; SPF: specific pathogen-free;
TMAP:
tumor-associated
microtubule-associated protein; TUNEL: TdT-mediated dUTP nick end labeling; V: volume; WT: wild type.